|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Coapt Systems, Inc. Launches ENDOTINE Midface Bone 4.5 For Vertical Midface Suspension; Fifth In A Series Of New ENDOTINE Product Offerings
10/19/2005 5:10:51 PM
PALO ALTO, Calif.--(BUSINESS WIRE)--April 28, 2005--Coapt Systems, Inc., developer of bioabsorbable implants for the fixation of soft tissue in the plastic and reconstructive surgery markets, announced today that it has released the ENDOTINE Midface(TM) Bone 4.5 for commercial sale in the U.S. market to coincide with the annual congress of the American Society of Aesthetic and Plastic Surgeons (ASAPS) that begins in New Orleans, Louisiana this week.
"This product is the fifth in a series of new products that we will launch over the next twelve months that will enable us to build an enduring franchise in the plastic surgery market," said John Kraczkowsky, Senior Vice President, Sales and Marketing. "The ENDOTINE Midface Bone product provides our customers with another option to suspend the midface that has many advantages when compared to prior suspension techniques. This new device completes our midface product offering, now enabling surgeons to elevate the cheek in any direction from vertical to oblique."
|
|
|
|
|
|
|
|
|
|
|